title: Subcutaneous immunoglobulin for patients with antibody deficiency.
abstract: This article provides an overview on the management of primary immunodeficiency, and discusses the pharmacokinetics of subcutaneous and intravenous immunoglobulin and the relationship between blood levels and therapeutic effects in both treatments. The article will further highlight both treatments' efficacy in preventing infections and the risk of systemic side effects with each treatment.
authors.affiliation: Department of Immunology, Manchester Royal Infirmary.
authors.forename: Matthew
authors.initials: M
authors.lastname: Helbert
authors.forename: Alex
authors.initials: A
authors.lastname: Farragher
mesh_terms: D000279:Administration, Cutaneous; D000906:Antibodies / Q000191:economics / Q000276:immunology*; D003365:Costs and Cost Analysis; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage* / Q000191:economics; D007153:Immunologic Deficiency Syndromes / Q000191:economics / Q000628:therapy*
chemical_list: D000906:Antibodies; D007136:Immunoglobulins